FactSet Research Systems Inc. (FDS) Rallies 5.73% After Earnings
· Stocks · QuoteReporter
Post Earning Analysis
FactSet Research Systems Inc. (FDS) Rallies 5.73% After Earnings
FactSet Research Systems Inc. is a leading provider of financial data and analytics tools, serving professionals across the global financial industry. The current investment case for FactSet is a "buy," primarily due to its robust subscription-based revenue model, which ensures steady cash flow and financial stability in a volatile market environment.
FactSet's recent strategic partnership with Google Cloud to enhance AI capabilities in financial intelligence, announced on June 30, 2026, significantly bolsters the bull case for the company's stock. This collaboration is poised to enhance FactSet's competitive edge by integrating advanced AI technologies, which could lead to improved efficiency and innovative product offerings in the financial data sector. Such technological advancements are critical as they can attract new customers and increase retention among existing ones by offering more sophisticated analytical tools.
However, despite these positive developments, FactSet's stock experienced a decline following the release of its third-quarter earnings on July 1, 2026. The company surpassed quarterly profit estimates, indicating robust demand for its data and analytics services. Yet, the stock slipped due to a disappointing outlook, suggesting potential concerns about future revenue growth or profitability that could temper investor enthusiasm in the near term.
Investors should closely monitor FactSet's next quarterly earnings release. This will provide crucial insights into whether the strategic initiatives like the Google Cloud partnership are translating into financial performance that can counterbalance the pessimistic outlook that has recently weighed on the stock.
The current price of the stock is $243.26, marking an increase of $5.73 or approximately 5.73% today. The Relative Strength Index (RSI) stands at 56.87, indicating neither overbought nor oversold conditions, suggesting a potential continuation of the current price momentum. The Moving Average Convergence Divergence (MACD) at -0.97, however, signals a negative divergence, hinting at a possible upcoming reversal or slowdown in momentum.
The stock is trading above its 50-day moving average (MA50) by 5.65% but remains below its 200-day moving average (MA200) by -2.48%, indicating a mixed signal where the stock might be at a pivot point between short-term gains and long-term uncertainty.
Currently, the stock is significantly off its 52-week high by -45.43%, yet it has recovered 32.81% from its 52-week low, suggesting a recovery phase within a broader bearish trend. The price action, especially with today's notable increase, implies that market sentiment is cautiously optimistic, possibly due to recent developments or earnings expectations, but the overall trend remains cautious given the distance from the 52-week high.
Earnings Trend Table
| Earnings Date | Date | Estimate EPS | Reported EPS | Surprise % |
|---|---|---|---|---|
| 2025-06-23 07:00:00-04:00 | 2025-06-23 | 4.29 | 4.27 | -0.56 |
| 2025-03-20 06:01:00-04:00 | 2025-03-20 | 4.16 | 4.28 | 2.85 |
| 2024-12-19 06:54:00-05:00 | 2024-12-19 | 4.26 | 4.37 | 2.46 |
| 2024-09-19 06:56:00-04:00 | 2024-09-19 | 3.62 | 3.74 | 3.30 |
| 2024-06-21 06:55:00-04:00 | 2024-06-21 | 3.90 | 4.37 | 11.97 |
| 2024-03-21 06:58:00-04:00 | 2024-03-21 | 3.88 | 4.22 | 8.65 |
| 2023-12-19 07:00:00-05:00 | 2023-12-19 | 4.11 | 4.12 | 0.19 |
| 2023-09-21 07:00:00-04:00 | 2023-09-21 | 3.51 | 2.93 | -16.41 |
The earnings per share (EPS) trend for the company has shown a notable recovery and growth trajectory over the recent quarters. Starting from a significant miss in Q3 2023 with an EPS of 2.93 against an estimate of 3.51 (a -16.41% surprise), the company has since reversed this downturn and improved its performance consistently. The following quarters saw a gradual increase in EPS: Q4 2023 at 4.12, Q1 2024 at 4.22, Q2 2024 at 4.37, Q3 2024 at 3.74, Q4 2024 at 4.37, and Q1 2025 at 4.28, before a slight dip in Q2 2025 to 4.27.
This recovery and growth phase, particularly from Q3 2023 to Q1 2025, where EPS consistently met or exceeded estimates, indicates a strong rebound and operational improvement. However, the slight decrease in EPS in Q2 2025 to 4.27 from 4.28 in Q1 2025, although minimal, could suggest a potential deceleration in earnings growth.
This trend supports a cautiously optimistic investment thesis, as the company has demonstrated the ability to surpass expectations and recover from lows effectively. However, the recent slight dip could be a signal to watch for any emerging challenges or a plateau in growth. Looking forward, the trajectory suggests that the company might face a tighter challenge in beating the next quarter's consensus, given the slight deceleration observed in the most recent quarter.
Dividend Payments Table
| Date | Dividend |
|---|---|
| 2026-05-29 | 1.16 |
| 2026-02-27 | 1.1 |
| 2025-11-28 | 1.1 |
| 2025-08-29 | 1.1 |
| 2025-05-30 | 1.1 |
| 2025-02-28 | 1.04 |
| 2024-11-29 | 1.04 |
| 2024-08-30 | 1.04 |
The dividend profile of the company under review shows a pattern of growth over the recent years. The quarterly dividend has increased from $1.04 in 2024 to $1.16 by mid-2026, indicating a growth trend. Specifically, the dividend was raised from $1.04 to $1.10 in early 2025 and then to $1.16 in mid-2026. This progression suggests a commitment to increasing shareholder returns.
The increase from $1.04 to $1.16 over approximately two years represents a cumulative increase of about 11.5%. This growth trajectory, while modest, is a positive signal for income investors looking for steadily growing payouts. However, without specific data on the company's earnings and free cash flow, it's challenging to assess the sustainability of these dividends fully. If the company's free cash flow adequately covers the dividend, this would further enhance the attractiveness of the stock to income-focused investors.
Given the observed dividend growth and assuming a stable or improving free cash flow, this stock could be appealing compared to fixed income alternatives like the 10-year Treasury, especially if the yield on the stock exceeds that of the Treasury securities. This analysis assumes the market conditions and company performance support the ongoing dividend payments.
The most recent rating changes for the stock in question show a mix of opinions from major financial institutions. On June 18, 2026, Rothschild & Co Redburn downgraded the stock from Neutral to Sell with a target price of $215. Earlier, on February 17, 2026, BofA Securities resumed coverage with an Underperform rating and a target price of $195. On a more positive note, Morgan Stanley upgraded the stock from Underweight to Equal-Weight on December 17, 2025, with a target price of $307. Additionally, UBS upgraded the stock from Neutral to Buy on September 22, 2025, setting a high target price of $425.
The analyst consensus appears divided with both bullish and bearish perspectives. The target prices range significantly from $195 to $425, indicating a broad spectrum of expectations about the stock's future performance. The most bullish outlook from UBS at $425 suggests a strong upside potential, which might be credible if the company's fundamentals are robust and improving.
Given the wide range of target prices and mixed ratings, investors might find the consensus challenging to navigate. Trusting the consensus would depend heavily on one's view of the company's ability to meet the more optimistic projections like those of UBS. If the fundamentals align with UBS's outlook, trusting the bullish consensus could be justified. However, if the company's performance is closer to the lower end of expectations, a more cautious approach would be advisable.
With a current price of $243.26 and a range of analyst targets suggesting potential downside to $195 and upside to $425, the market may be significantly underestimating the growth prospects of this stock. The average target price, considering the most recent ratings, indicates a potential upside of approximately +67% to the highest target set by UBS at $425. This substantial gap suggests that the EPS and dividend trends are likely more robust than the market currently prices in, especially if the upgrades by major firms like UBS and Morgan Stanley are driven by underlying improvements in business fundamentals.
The market might be underpricing the company's strategic initiatives or market expansion plans, which could be catalyzing the bullish outlook from some analysts. Conversely, the lower target prices from BofA Securities and Rothschild & Co Redburn indicate there is a non-consensus view on the company's risk factors or competitive challenges.
A critical forward catalyst to watch is the upcoming quarterly earnings report. Should the company report earnings that significantly exceed market expectations, this could validate the higher price targets and potentially lead to further upgrades. Conversely, a miss on earnings or revised downwards guidance could align the stock closer to the more conservative estimates, confirming the bearish outlook from some analysts.
Disclaimer
The content on MarketsFN.com is provided for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or trading guidance. All investments carry risk and past performance does not guarantee future results. You are solely responsible for your investment decisions and should conduct independent research and consult a qualified financial advisor before acting. MarketsFN.com and its authors are not liable for any losses or damages arising from the use of this information.